 |
|
yttrium Y 90 humanized epratuzumab
A radioimmunotherapeutic humanized murine monoclonal antibody (LL2) directed against the CD22 pan-B-cell antigen and chelated to the radioisotope yttrium-90 (Y 90). Y 90 humanized monoclonal antibody LL2 binds to tumor cells expressing CD22, delivering a cytotoxic dose of beta radiation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | Y 90 epratuzumab
Y 90 Humanized Monoclonal Antibody LL2
Y 90 monoclonal antibody LL2
Y90 Humanized Epratuzumab
Yttrium Y 90 Humanized Monoclonal Antibody LL2
yttrium Y 90 MOAB LL2
yttrium Y-90 epratuzumab | | | | Abbreviation: | | Y90 MOAB LL2 | | |
|
|
